Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Piramal
Pharma
Eisai, ex-NMPA official, Pfizer-Summit—Fierce Pharma Asia
Eisai initiated a U.S. restructuring program. A former China NMPA deputy director is under investigation. Pfizer formed a collaboration with Summit.
Angus Liu
Feb 28, 2025 8:45am
FDA hits Piramal with 6-observation Form 483 at India API plant
Feb 26, 2025 10:22am
Piramal to pump $80M into expansion of Kentucky injectables site
Oct 1, 2024 8:12am
Piramal API plant in Michigan hit with FDA Form 483 write-up
Feb 9, 2024 10:51am
Piramal gets FDA resolution in KY; begins production in MI
Feb 16, 2023 10:32am
CDMO Piramal earmarks $74M for upgrades to UK facilities
Feb 8, 2022 9:55am
